| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 2.948.944.361 $ | +29.416.016 $ | +0,3 % | 8 | 3.549.362.455 $ | +1.943.353.946 $ | +56,4 % | 11 | 1.294.309.153 $ | +404.862.721 $ | +60,0 % | 6 | ||||
| FINANCIAL COUNSELORS INC | → 0 | 1.277.300.000 $ | +58.000.000 $ | +4,8 % | 1 | 1.219.300.000 $ | +1.219.300.000 $ | 1 | |||||||
| Guardant Health, Inc. | GH | → 0 | Neutral | 308.353.321 $ | +22.361.321 $ | +7,8 % | 1 | 285.992.000 $ | +26.444.707 $ | +10,2 % | 1 | 259.547.293 $ | +38.377.293 $ | +17,4 % | 1 |
| Immunovant, Inc. | IMVT | → 0 | Schwach | 286.329.960 $ | -6.685.643 $ | -2,3 % | 1 | 293.015.603 $ | +136.186.622 $ | +86,8 % | 1 | ||||
| Structure Therapeutics Inc. | GPCR | → 0 | Neutral | 206.288.674 $ | -79.685.764 $ | -27,9 % | 1 | 285.974.438 $ | +167.931.730 $ | +142,3 % | 1 | ||||
| Tarsus Pharmaceuticals, Inc. | TARS | → 0 | Schwach | 252.540.000 $ | +6.569.696 $ | +2,7 % | 1 | 245.970.304 $ | +67.680.304 $ | +38,0 % | 1 | 178.290.000 $ | +107.397.500 $ | +151,5 % | 1 |
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 249.873.000 $ | +65.313.000 $ | +35,4 % | 1 | 184.560.000 $ | +76.500.000 $ | +70,8 % | 1 | ||||
| IONIS PHARMACEUTICALS INC | IONS | → 0 | Schwach | 249.128.780 $ | +55.863.877 $ | +28,9 % | 1 | ||||||||
| DYNAVAX TECHNOLOGIES CORP | DVAX | → 0 | 241.871.248 $ | +85.708.602 $ | +54,9 % | 1 | |||||||||
| CYTOKINETICS INC | CYTK | → 0 | Schwach | 212.032.853 $ | -24.295.147 $ | -10,3 % | 1 | 236.328.000 $ | +115.732.000 $ | +96,0 % | 1 | ||||
| Axsome Therapeutics, Inc. | AXSM | → 0 | Schwach | 185.922.000 $ | -24.114.000 $ | -11,5 % | 1 | 210.036.000 $ | +100.731.000 $ | +92,2 % | 1 | ||||
| Apellis Pharmaceuticals, Inc. | APLS | → 0 | 182.337.406 $ | -12.342.594 $ | -6,3 % | 1 | 194.680.000 $ | +13.631.355 $ | +7,5 % | 1 | 181.048.645 $ | +59.878.645 $ | +49,4 % | 1 | |
| Akero Therapeutics, Inc. | → 0 | 189.966.435 $ | +27.613.406 $ | +17,0 % | 1 | ||||||||||
| Maze Therapeutics, Inc. | MAZE | → 0 | Sehr schwach | 175.930.009 $ | +73.534.773 $ | +71,8 % | 1 | ||||||||
| 2.948.944.361 $ | +29.416.016 $ | +0,3 % | 8 | 3.549.362.455 $ | +1.943.353.946 $ | +56,4 % | 11 | 1.294.309.153 $ | +404.862.721 $ | +60,0 % | 6 | ||||